Clinical Trial Update: Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine) [Phase 1, Phase 2]

View source ↗

Summary

Arbor Biotechnologies is conducting a Phase 1/2 trial of ABO-101 for Primary Hyperoxaluria Type 1, and the study is currently recruiting under the redePHine pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Drugs mentioned

• ABO-101

Snippet

Sponsor: Arbor Biotechnologies | Conditions: Primary Hyperoxaluria Type 1 (PH1) | Phase 1, Phase 2 | Status: RECRUITING